SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-18-010766
Filing Date
2018-02-20
Accepted
2018-02-20 17:04:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 18471
2 GRAPHIC g27518bgi001.jpg GRAPHIC 5151
  Complete submission text file 0001104659-18-010766.txt   26617
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations